Brokerages Set Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Price Target at $93.50
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) has received a consensus rating of “Moderate Buy” from the fourteen research firms that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1-year target price […]
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) has received a consensus rating of “Moderate Buy” from the fourteen research firms that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1-year target price […]
